V8879

Vincristine sulfate salt

95.0-105.0% (HPLC), powder or crystals

• Synonim(y): 22-Oxovincaleukoblastine sulfate salt, Leurocristine sulfate salt, VCR
• Wzór empiryczny (zapis Hilla): C₄₆H₅₆N₄O₁₀ · H₂SO₄
• Numer CAS: 2068-78-2
• Masa cząsteczkowa: 923.04
• Beilstein: 3924631
• Numer WE: 218-190-0
• Numer MDL: MFCD00084729
• Kod UNSPSC: 51111767
• Identyfikator substancji w PubChem: 57654729
• NACRES: NA.85

Właściwości

• pochodzenie biologiczne: Streptomyces roseosporus
• Próba: 95.0-105.0% (HPLC)
• Formularz: powder or crystals
• warunki przechowywania: (Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.)
• kolor: white to light yellow
• spektrum działania antybiotyku: neoplastics
• Tryb działania: protein synthesis | interferes
• temp. przechowywania: −20°C
• ciąg SMILES: OS(O)(=O)=O.CC[C@]1(O)CC2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)C7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67C89)C(=O)OC)C1
• InChI: 1S/C46H56N4O10.H2O4S/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6;1-5(2,3)4/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3;(H2,1,2,3,4)/t28-,37-,38+,39+,42-,43+,44+,45-,46-;/m0./s1
• Klucz InChI: AQTQHPDCURKLKT-PNYVAJAMSA-N

Opis

Zastosowanie

Vincristine is an antitumor alkaloid isolated from Vinca Rosea. It is used to treat acute leukaemia, malignant lymphoma, Hodgkin′s disease, acute erythraemia, acute panmyelosis, breast cancer, Kaposi′s sarcoma and testicular cancer. Vincristine is widely used in cancer research. It is used to study multi-drug resistance. It is used to inhibit cell cycle progression at M-phase and to inhibit monoamine oxidase (MAO) .

Działania biochem./fizjol.

Vincristine is a plant alkaloid that inhibits microtubule assembly by binding tubulin and inducing coiled spiral aggregate formation. It arrests cell cycle in G2/M-phase by blocking mitotic spindle formation. Vincristine triggers Raf-1 activation, phosphorylation of bcl-2-family proteins, induction of p53 expression, and apoptosis in several tumor cell lines. It inhibits VEGF production in leukemia cell lines. It is a substrate for Pgp and CYP3A4. MRP1 transports vincristine in an ATP- and GSH-dependent manner. Vincristine has some immunosuppressant effect. Vincristine may also interfere with amino acid, cyclic AMP, and glutathione metabolism, calmodulin-dependent Ca2+-transport, cellular respiration, and nucleic acid and lipid biosynthesis.

Komentarz do analizy

Freely soluble in water, Soluble in methanol, slightly soluble in ethanol

Inne uwagi

Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS06,GHS08
• Hasło ostrzegawcze: Danger
• Zwroty wskazujące rodzaj zagrożenia: H300,H341,H361fd
• Zwroty wskazujące środki ostrożności: P202 - P264 - P270 - P280 - P301 + P310 - P405
• Klasyfikacja zagrożeń: Acute Tox. 2 Oral - Muta. 2 - Repr. 2
• Kod klasy składowania: 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable